Last Updated: September, 2024
Trusted by 200+ Clients
The report provides a detailed analysis essential for establishing a Montelukast (Singulair) production plant. It encompasses all critical aspects necessary for Montelukast (Singulair) production, including the cost of Montelukast (Singulair) production, Montelukast (Singulair) plant cost, Montelukast (Singulair) production costs, and the overall Montelukast (Singulair) production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Montelukast (Singulair) production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Montelukast (Singulair) is an FDA-approved medicine that is widely used for the treatment and prevention of asthma and other allergic symptoms. This drug is utilized for the treatment of chronic asthma, prophylaxis, and exercise-induced bronchoconstriction. Moreover, it is also employed in relieving symptoms of seasonal and perennial allergic rhinitis in both children and adults.
The market for Montelukast (Singulair) is predominantly driven by its extensive usage in the pharmaceutical industry as an orally dosed drug for the treatment of allergic symptoms, which significantly boosts its market growth. Additionally, its employment as a medicine to treat chronic asthma and exercise-induced bronchoconstriction further enhances its demand in the medical and pharmaceutical industries. Furthermore, several factors, such as the availability of raw materials, cost, and pricing, compliance with pharmaceutical regulations, quality standards, technological advancements, environmental considerations, sustainability practices, distribution (including trading and shipping), logistics, and safety standards, etc., influence industrial montelukast procurement globally.
The extensive Montelukast (Singulair) production cost report consists of the following industrial production process:
Montelukast (Singulair) belongs to the class of quinolones and appears as an off-white powder that completely dissolves in water, ethanol, and methanol. The molecular formula of the compound is C35H36CLNO3S, and its molecular weight is 586.2 g/mol. The IUPAC name of the compound is 2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid. This medication is sold under the name Singulair. It is a leukotriene receptor blocker. This medicine is administered orally in the form of tablets. The melting point of the compound is 275.9F.
Montelukast (Singulair) Production Cost Report
Choose What's Right for You
Pay Via
| Particulars | Details |
|---|---|
| Product Name | Montelukast (Singulair) |
| Scope | Production Process: Process Flow, Material Flow, Material Balance Raw Material and Product Specifications: Raw Material Consumption, Product and Co-product Generation Land and Site Cost: Offsites/Civil Works, Equipment Cost, Auxiliary Equipment Costs, Contingency, Engineering and Consulting Charges, Working Capital Variable Cost: Raw Material, Utilities, Other Variable Costs Fixed Cost: Labor Requirements and Wages, Overhead Expenses, Maintenance Charges, Other Fixed Costs Financing Costs: Interest on Working Capital, Interest on Loans Other Costs: Depreciation Charges, General Sales and Admin Cost |
| Currency | US$ (Data can also be provided in the local currency) |
| Pricing and Purchase Options | Basic: US$ 2499 Premium: US$ 3499 Enterprise: US$ 4799 |
| Customization Scope | The report can be customized as per the requirement of the customer |
| Post-Sale Analysts Report | 10-12 weeks of post-purchase analyst support after report delivery for any queries from the deliverable |
| Delivery Format | PDF and Excel format through email (editable version in PPT/Word format of the report can be also provided on special request) |
At Procurement Resource, we not only focus on optimizing the should cost of production for Montelukast (Singulair) but also provide our clients with extensive intel and rigorous information on every aspect of the production process. By utilizing a comprehensive cost model, we help you break down expenses related to raw materials, labor, and technology, offering clear pathways to savings. We also assist in evaluating the capital expenditure (CAPEX) and operating expenses (OPEX), which are often measured as cost per unit of production, such as USD/MT, ensuring that your financial planning is aligned with industry benchmarks.
We offer valuable insights on the top technology providers, in-depth supplier database, and best manufacturers, helping you make informed decisions to improve efficiency. Additionally, we design the most feasible layout for your production needs, ensuring the entire process runs smoothly. By minimizing the cash cost of production, we ensure that you stay competitive while securing long-term profitability in the growing Montelukast (Singulair) market. Partnering with Procurement Resource guarantees that every aspect of your production is cost-efficient, advanced, and tailored to your specific requirements.
Lead - Social & Development Research
Delivering procurement intelligence and supply chain analytics across healthcare, FMCG, and chemicals sectors, with expertise in cost modeling, vendor mapping, and spend optimization to support data-driven sourcing decisions and procurement outcomes.
Need more help?
Still Need Help?
Compare & Choose the Right Report Version for You
How to Order Your Report?
